Mendus AB (Sweden) Price History

IMMU Stock  SEK 7.25  0.30  3.97%   
If you're considering investing in Mendus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mendus AB stands at 7.25, as last reported on the 1st of February, with the highest price reaching 7.25 and the lowest price hitting 6.51 during the day. Mendus AB has Sharpe Ratio of -0.15, which conveys that the firm had a -0.15 % return per unit of risk over the last 3 months. Mendus AB exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mendus AB's Standard Deviation of 4.78, mean deviation of 3.07, and Risk Adjusted Performance of 5.0E-4 to check out the risk estimate we provide.
  
Mendus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1528

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIMMU

Estimated Market Risk

 3.36
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.51
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.15
  actual daily
0
Most of other assets perform better
Based on monthly moving average Mendus AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mendus AB by adding Mendus AB to a well-diversified portfolio.

Mendus AB Stock Price History Chart

There are several ways to analyze Mendus Stock price data. The simplest method is using a basic Mendus candlestick price chart, which shows Mendus AB price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 6, 202410.55
Lowest PriceJanuary 30, 20257.25

Mendus AB February 1, 2025 Stock Price Synopsis

Various analyses of Mendus AB's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Mendus Stock. It can be used to describe the percentage change in the price of Mendus AB from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Mendus Stock.
Mendus AB Accumulation Distribution 6,874 
Mendus AB Price Rate Of Daily Change 0.96 
Mendus AB Price Daily Balance Of Power(0.41)
Mendus AB Price Action Indicator 0.22 

Mendus AB February 1, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Mendus Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Mendus AB intraday prices and daily technical indicators to check the level of noise trading in Mendus Stock and then apply it to test your longer-term investment strategies against Mendus.

Mendus Stock Price History Data

The price series of Mendus AB for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 3.3 with a coefficient of variation of 9.45. Under current investment horizon, the daily prices are spread out with arithmetic mean of 8.83. The median price for the last 90 days is 8.67. The company completed 20:1 stock split on 3rd of June 2024.
OpenHighLowCloseVolume
01/31/2025 7.15  7.25  6.51  7.25  67,348 
01/30/2025 7.55  7.55  7.11  7.25  24,788 
01/29/2025 7.65  7.74  7.27  7.55  32,360 
01/28/2025 7.93  7.93  7.64  7.70  11,874 
01/27/2025 7.95  8.00  7.61  8.00  10,908 
01/24/2025 7.69  7.95  7.59  7.95  29,078 
01/23/2025 7.65  7.75  7.60  7.70  31,850 
01/22/2025 7.89  8.20  7.63  7.81  25,407 
01/21/2025 7.90  8.21  7.71  8.09  32,331 
01/20/2025 8.20  8.20  7.71  7.97  26,207 
01/17/2025 8.28  8.79  8.11  8.50  11,421 
01/16/2025 7.98  8.50  7.98  8.50  13,220 
01/15/2025 7.90  8.50  7.81  8.28  33,899 
01/14/2025 8.40  8.40  7.90  8.00  13,818 
01/13/2025 8.20  8.55  8.00  8.22  18,594 
01/10/2025 8.20  8.20  8.05  8.20  6,049 
01/09/2025 8.17  8.50  8.07  8.20  10,825 
01/08/2025 8.60  8.65  8.17  8.26  14,821 
01/07/2025 8.45  9.00  8.26  8.60  36,359 
01/03/2025 8.49  8.49  8.02  8.45  21,066 
01/02/2025 7.80  8.60  7.80  8.40  78,592 
12/30/2024 7.60  8.16  7.60  7.80  53,950 
12/27/2024 8.28  8.28  7.92  8.16  95,673 
12/23/2024 9.11  9.11  8.46  8.80  17,769 
12/20/2024 8.36  9.00  8.14  8.46  29,178 
12/19/2024 8.80  8.80  8.32  8.67  19,448 
12/18/2024 8.84  9.70  8.50  8.51  48,826 
12/17/2024 9.20  9.85  8.50  8.60  101,075 
12/16/2024 8.55  9.85  8.55  9.20  36,502 
12/13/2024 8.65  8.97  8.55  8.77  20,261 
12/12/2024 8.99  9.02  8.70  8.70  10,072 
12/11/2024 9.20  9.20  8.66  8.99  22,541 
12/10/2024 9.00  9.46  8.60  8.93  35,234 
12/09/2024 9.35  11.00  8.42  8.42  100,995 
12/06/2024 9.03  9.10  8.65  9.00  30,412 
12/05/2024 8.74  9.13  8.42  8.70  36,396 
12/04/2024 8.81  8.90  8.31  8.74  32,598 
12/03/2024 8.89  8.89  8.01  8.75  40,040 
12/02/2024 8.39  8.90  8.10  8.89  30,818 
11/29/2024 8.71  8.71  8.31  8.48  36,576 
11/28/2024 8.43  8.71  8.31  8.71  25,544 
11/27/2024 8.19  9.20  8.19  8.43  28,231 
11/26/2024 8.18  8.27  8.00  8.15  14,716 
11/25/2024 8.10  8.36  8.10  8.18  23,450 
11/22/2024 8.57  8.57  8.00  8.32  45,926 
11/21/2024 8.80  9.20  8.09  8.47  65,132 
11/20/2024 9.40  9.40  8.81  9.24  19,207 
11/19/2024 9.10  9.34  9.00  9.24  13,534 
11/18/2024 9.10  9.40  9.10  9.32  11,292 
11/15/2024 9.00  9.40  9.00  9.40  18,948 
11/14/2024 9.70  9.70  9.10  9.24  7,747 
11/13/2024 9.20  9.70  9.02  9.70  13,811 
11/12/2024 9.70  9.70  8.69  9.50  46,620 
11/11/2024 9.90  10.32  9.20  9.75  25,676 
11/08/2024 10.17  10.29  9.64  10.00  53,334 
11/07/2024 10.55  10.55  10.04  10.29  20,942 
11/06/2024 10.01  10.55  10.00  10.55  71,443 
11/05/2024 10.15  10.48  9.65  10.48  84,713 
11/04/2024 10.35  10.36  9.65  10.16  55,152 
11/01/2024 10.30  10.36  10.15  10.35  12,928 
10/31/2024 10.25  10.44  10.15  10.35  47,711 

About Mendus AB Stock history

Mendus AB investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mendus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mendus AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mendus AB stock prices may prove useful in developing a viable investing in Mendus AB
Its lead product is ilixadencel, which is in Phase II clinical trial for the treatment of kidney cancer and Phase IbII clinical trials for the treatment of head and neck cancer, non-small cell lung cancer, and gastric cancer, as well as is in a Phase III clinical trials to treat liver cancer and gastrointestinal stromal tumors. Immunicum AB has a collaboration agreement with Merck KGaA and Pfizer Inc. to evaluate ilixadencel in combination with avelumab in multi-indication Phase IbII study. Immunicum is traded on Stockholm Stock Exchange in Sweden.

Mendus AB Stock Technical Analysis

Mendus AB technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mendus AB technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mendus AB trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Mendus AB Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Mendus AB's price direction in advance. Along with the technical and fundamental analysis of Mendus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mendus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Mendus Stock Analysis

When running Mendus AB's price analysis, check to measure Mendus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mendus AB is operating at the current time. Most of Mendus AB's value examination focuses on studying past and present price action to predict the probability of Mendus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mendus AB's price. Additionally, you may evaluate how the addition of Mendus AB to your portfolios can decrease your overall portfolio volatility.